Lorenzo and collaborators (2020) extended their previous work to predict tumour shrinkage under HT and Jain et al. (2011) studied the response of cancer cells under intermittent HT to predict treatment failure also taking into account PSA. The gene discussed is KLK3; the disease is cancer.